Inventor · disambiguated record
Joerg Kaufmann
Also filed as: KAUFMANN JOERG
14 granted patents·8 pending applications·58 citations·filing 1998–2022
89Inventor score
Top patents by PatentIndex Score
22 records- 0189US7700359B2Gene products differentially expressed in cancerous cellsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Apr 20, 2010·31 cites·9 claims
- 0282US6566063B1Methods for determining metastatic potential of breast cancer cells by detecting GSEF gene product expressionCHIRON CORP·Filed 2000·Granted May 20, 2003·14 cites·12 claims
- 0378US6589745B2CIF130 inhibits cell cycle progressionCHIRON CORP·Filed 2002·Granted Jul 8, 2003·3 cites·16 claims
- 0472US7081517B2Genes differentially expressed in breast cancerCHIRON CORP·Filed 2002·Granted Jul 25, 2006·2 cites·1 claims
- 0570US6423822B1Human CIF130 polypeptidesCHIRON CORP·Filed 2000·Granted Jul 23, 2002·1 cites·10 claims
- 0669US9133515B2Use of VEGFR1 as a biomarkerSILENCE THERAPEUTICS AG·Filed 2013·Granted Sep 15, 2015·1 cites·4 claims
- 0761US2003113791A1CIF130 inhibits cell cycle progressionCHIRON CORP·Filed 2003·Application pending·0 cites
- 0857US8236928B2Genes differentially expressed in breast cancerKAUFMANN JOERG·Filed 2006·Granted Aug 7, 2012·0 cites·5 claims
- 0956US2023295651A1Recombinant nucleic acid construct and use thereofPANTHERNA THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 1054US2013196314A1Genes Differentially Expressed in Breast CancerKAUFMANN JOERG·Filed 2012·Application pending·0 cites
- 1154US2012308569A1Gene products differentially expressed in cancerous cellsCHAN VIVIEN W·Filed 2012·Application pending·0 cites
- 1252US8221983B2Gene products differentially expressed in cancerous cellsCHAN VIVIEN W·Filed 2010·Granted Jul 17, 2012·0 cites·11 claims
- 1352US2005043263A1Use of double-stranded ribonucleic acid for inducing cell lysisATUGEN AG·Filed 2004·Application pending·0 cites
- 1451US6303372B1cDNA molecule encoding human CIF130CHIRON CORP·Filed 1999·Granted Oct 16, 2001·4 cites·17 claims
- 1549US7867731B2HX2004-6 polypeptide expressed in cancerous cellsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Jan 11, 2011·0 cites·13 claims
- 1648US11796540B2Methods for modulating signal intensity in interaction assaysROCHE DIAGNOTICS OPERATIONS INC·Filed 2019·Granted Oct 24, 2023·0 cites·10 claims
- 1747US7605246B2Genes differentially expressed in breast cancerNOVARTIS VACCINES & DIAGNOSTIC·Filed 2001·Granted Oct 20, 2009·0 cites·19 claims
- 1846US11532845B2Battery cellVOLKSWAGEN AG·Filed 2019·Granted Dec 20, 2022·0 cites·14 claims
- 1946US2006240022A1Factor involved in metastasis and uses thereofATUGEN AG·Filed 2003·Application pending·0 cites
- 2042US2015368650A1Use of vegfr1 as a biomarkerSILENCE THERAPEUTICS GMBH·Filed 2015·Application pending·0 cites
- 2135US6174679B1CIF150/hTAFII150 is necessary for cell cycle progressionCHIRON CORP·Filed 1998·Granted Jan 16, 2001·2 cites·26 claims
- 2233US2010285038A1Factor Involved in Metastasis and Uses ThereofKLIPPEL-GIESE ANKE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joerg Kaufmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →